Advertisement

Topics

FDA approves leukemia treatment developed by Celgene, Agios

08:08 EDT 1 Aug 2017 | Reuters

(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Celgene Corp and Agios Pharmaceuticals Inc's oral treatment for acute myeloid leukemia (AML) patients with a specific genetic mutation.

Original Article: FDA approves leukemia treatment developed by Celgene, Agios

NEXT ARTICLE

More From BioPortfolio on "FDA approves leukemia treatment developed by Celgene, Agios"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Leukemia
Leukemia is a type of cancer of the blood or bone marrow characterized by an abnormal increase of immature white blood cells called "blasts". Leukemia is a broad term covering a spectrum of diseases. In turn, it is part of the even broader grou...